Should paroxetine 40 mg daily be temporarily discontinued in an older adult with a urinary‑tract infection and acute delirium, and is there a risk of withdrawal (discontinuation syndrome)?

Do Not Hold Paroxetine in Acute Delirium from UTI

Continue paroxetine 40 mg daily during acute delirium from UTI in this older adult, but be vigilant about anticholinergic burden and consider the broader medication profile. Abrupt discontinuation of paroxetine carries significant risk of withdrawal syndrome, particularly at this dose, while the drug itself is not the primary cause of delirium in this clinical context.

The Delirium-UTI Relationship

The delirium is almost certainly caused by the UTI and underlying host factors—not by paroxetine continuation. Current evidence strongly indicates that bacteriuria and delirium in older adults reflect concurrent conditions rather than a causal relationship 1. The 2019 IDSA guidelines emphasize that observational data show the relationship between delirium and bacteriuria is attributable to underlying host factors rather than true infection-related inflammation 1. Multiple 2024 guidelines confirm that older adults frequently present with atypical UTI symptoms including altered mental status and confusion 2.

The appropriate intervention is treating the UTI itself, not discontinuing established psychiatric medications.

Paroxetine Withdrawal Risk is Real and Significant

Paroxetine has the highest risk of discontinuation syndrome among SSRIs due to its short half-life and lack of active metabolites 3, 4. At 40 mg daily—a moderate-to-high dose—abrupt cessation would be particularly problematic:

• Withdrawal symptoms occur in approximately 10-11% of patients (41 of 385 patients in one retrospective analysis) 5
• Symptoms include marked sleep disturbances, dizziness, sensory disturbances, and can be "sudden and impairing" 3
• Abrupt discontinuation significantly increases withdrawal risk compared to tapering 5
• Symptoms typically emerge within days and can worsen the clinical picture, potentially being mistaken for worsening delirium

The FDA label confirms paroxetine's 21-hour half-life with nonlinear kinetics at higher doses 6, meaning plasma levels drop relatively quickly after discontinuation.

Paroxetine-Specific Concerns in Older Adults

While paroxetine should generally be avoided as a first-line agent in older adults due to anticholinergic effects 7, this patient is already established on therapy. The 2015 American Family Physician guidelines state that "paroxetine is associated with more anticholinergic effects...and should not be used in older adults" 7—but this refers to initiation, not acute discontinuation during delirium.

Key considerations:

• Paroxetine requires dose reduction in renal impairment (creatinine clearance 30-60 mL/min shows 2-fold increase in plasma concentrations) 6
• Elderly patients show 70-80% higher plasma concentrations than younger adults 6
• If the patient has renal impairment from UTI/sepsis, drug levels may be elevated, but this still doesn't warrant abrupt cessation

Clinical Management Algorithm

Immediate actions (during acute delirium):

1. Continue paroxetine 40 mg daily without interruption
2. Treat the UTI with appropriate antibiotics per culture/sensitivity
3. Review ALL medications for anticholinergic burden—paroxetine may be contributing but is not the sole culprit
4. Monitor for serotonin syndrome if fluoroquinolones are used (drug interaction concern) 7
5. Ensure adequate hydration and address other delirium precipitants 8

Post-acute phase (after delirium resolves):

• If long-term antidepressant therapy is still indicated, consider transitioning to a more appropriate SSRI (citalopram, escitalopram, or sertraline) 7
• Use a slow taper over 3-4 weeks minimum if discontinuing 4
• Some experts recommend bridging with fluoxetine to cover discontinuation symptoms due to its long half-life 4

Common Pitfalls to Avoid

1. Do not attribute delirium to paroxetine and abruptly stop it—this creates a second iatrogenic problem
2. Do not assume all bacteriuria requires treatment—asymptomatic bacteriuria is common in older adults and should not be treated 1
3. Do not overlook polypharmacy—review the entire medication list for anticholinergic burden, not just paroxetine 2, 9
4. Do not forget renal function—if creatinine clearance is impaired, paroxetine levels may be elevated but gradual dose reduction (not abrupt cessation) is appropriate 6

The Evidence on Treating vs Not Treating Delirium with Antibiotics

Recent evidence shows that treating asymptomatic bacteriuria in delirious patients does not improve delirium outcomes and may cause harm. Delirious patients treated for asymptomatic bacteriuria had poorer functional outcomes (adjusted OR 3.45) and higher rates of C. difficile infection 1. However, if this patient has true UTI with systemic signs (fever, rigors, clear-cut delirium as defined by DSM-5 criteria), then antibiotic treatment is appropriate 2.

Bottom line: Continue the paroxetine, treat the UTI if it meets diagnostic criteria, and plan any medication optimization for after the acute illness resolves.